002620.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

Stats
Today's Volume	19 244.00
Average Volume	42 827.00
Market Cap	158.12B
EPS	KRW0 ( 2024-02-20 )
Next earnings date	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW30.36 (0.29%)

Volume Correlation

Long: -0.22 (neutral)

Short: -0.12 (neutral)

Signal:(41.2) Neutral

Jeil Pharma Holdings Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jeil Pharma Holdings Inc Correlation - Currency/Commodity

0.56
( weak )

0.48
( neutral )

0.08
( neutral )

0.53
( weak )

Jeil Pharma Holdings Inc Financials

Annual	2023
Revenue:	KRW794.71B
Gross Profit:	KRW201.82B (25.40 %)
EPS:	KRW-1 058.54

Q4	2023
Revenue:	KRW200.44B
Gross Profit:	KRW51.95B (25.92 %)
EPS:	KRW-1 762.67

Q3	2023
Revenue:	KRW194.77B
Gross Profit:	KRW47.03B (24.15 %)
EPS:	KRW-16.95

Q2	2023
Revenue:	KRW199.34B
Gross Profit:	KRW50.44B (25.30 %)
EPS:	KRW81.97

Financial Reports:

No articles found.

Jeil Pharma Holdings Inc

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.